A pharmaceutical company operating across several European markets needed earlier visibility into how changing public discussion and regulatory debate could affect demand, reputation, and future communications strategy. Traditional market research provided useful historical insights, but it lacked the speed required to identify emerging shifts while they were still developing.
Perceptica’s market intelligence monitoring tracked media coverage, regulatory commentary, healthcare stakeholders, analyst opinions, and public conversation across multiple markets in real time. The analysis revealed a rapidly growing narrative around drug affordability, access, and reimbursement policy, weeks before the topic became a dominant industry discussion.
The research also identified:
- which stakeholders were driving the conversation,
- which markets were seeing the fastest escalation in media attention,
- and how sentiment differed between regulators, industry voices, and the public.
Using these insights, the client adapted its communications strategy, prepared leadership messaging in advance, and aligned internal teams around emerging policy risks before formal regulatory proposals were introduced.
As a result, the company strengthened stakeholder readiness, reduced reputational exposure, and positioned itself as a proactive voice in the evolving healthcare debate rather than reacting after the narrative had already shifted.